
What’s Now and Next
We apply our core philosophy—Intelligence That Works—to provide deep, of-the-moment analysis of the most important issues facing the organizations we serve. Read on for data-driven insights with clear perspectives, always focused on what happens next—and how…

Prepare for what's next.
ThinkSet magazine, a BRG publication, provides nuanced, multifaceted thinking and expert guidance that help today’s business leaders adopt a more strategic, long-term mindset to prepare for what’s next.
Explore Insights
Discover the actionable intelligence that sets us apart.
Search results
PodcastNurse Executive Podcast
2025
Publication2025 US Healthcare & Life Sciences Transactions Outlook
March 2025
PublicationStrategies for Hospitals to Preserve Cash in the Face of Rising Cost
January 2025
PublicationAn Update on Post-Pandemic Financial Relationships Between Manufacturers and Practitioners
October 2024
PublicationThe Compelling Case for Hospitals to Invest in Supply Chain Modernization
September 20, 2023
PublicationLessons Learned from COVID-19: How We Can Emerge as a More Operationally Efficient Healthcare System
September 13, 2023
PublicationQuarterly M&A Report | Q2 2023
Q2 2023
PublicationInflation Reduction Act Drug-Pricing Provisions: Financial Impact on Manufacturers
May 18, 2023
PublicationQuarterly M&A Report | Q1 2023
Q1 2023
PublicationInflation Reduction Act Drug-Pricing Provisions
February 8, 2023
PublicationBRG Review | Winter 2022 (volume 9)
Winter 2022
PublicationImproving Throughput Metrics with Reduced Labor Expenses
March 2021
Discover Events
Search results
30September 2025EventBuilding a High-Performing Surgery Program
Rick May discussed how leading surgery programs achieve clinical excellence and optimal financial performance.
19February 2025Event2025 AHLA Advising Providers: Legal Strategies for AMCs, Physicians, and Hospitals
Jerry Chang took part in the panel “Better Together: Joint Ventures between Health Systems and Other Providers Along the Care Continuum.”
13September 2023EventHave You Forecasted and/or Validated the Financial Impact the IRA Drug-Pricing Provisions Could Have on Your Company?
Austin Hay discussed drug-pricing provisions of the IRA.














